Sentence examples for progress in vitro from inspiring English sources

In our model of HPV16-mediated transformation, we did not find a consistent reduction of Smad3 protein levels as the cells progress in vitro.

No spontaneous immortalization indicate that most aneuploid cells are arrested or quiescent, an interpretation supported by our FACS-based analysis, which demonstrated that most cells of the hMSC subpopulation of enlarged and complex cells (β, phenotypically more senescent) were strongly aneuploid and essentially unable to progress in vitro.

While normal human keratinocytes (HKc) and human papillomavirus type 16-immortalized HKc (HKc/HPV16) are sensitive to the growth inhibitory effects of TGF-β, HKc/HPV16 develop resistance to TGF-β1 as they progress in vitro to a differentiation resistant phenotype (HKc/DR).

Gene expression profiling confirmed that with progressing in vitro differentiation Schwann cells reduced the expression of transcripts characteristic for neural crest stem cells, including genes involved in cell migration, cell proliferation and cell invasiveness.

We conducted a live observation of GV oocytes while progressing in vitro towards the MII stage, with the aim of giving an accurate description of the dynamics of this transition.

This review explores how recent progress in in vitro cancer and vascular models individually can be applied to the development of in vitro tumor angiogenesis models.

Recent progress in in vitro synthesis and insights into multiple antibiotic mechanisms combined in a single molecule make lantibiotics attractive model compounds for design of novel antiinfective drugs.

This review details the significant progress in in vitro translation for novel protein and non-natural amino acid containing peptide discovery platforms, as well as advances in the clinical-scale production of therapeutic proteins using cell-free transcription/translation.

This viewpoint review summarizes the progress on in vitro and animal scar models, stresses the limitations in the current models and identifies the future challenges if scar-free healing is to be achieved in the future.

11 The issue of low sensitivity is being tackled, 9a, 9c,  12 however, the work has either not progressed to in vitro or in vivo stages, or the aggregation process has relied upon electrostatic and non-covalent interactions.

They have shown distinct promise as a diagnostic agent for some cancers; bacteriocins have also tested as AIDS drugs [ 20] but have not progressed beyond in vitro tests on cell lines.